JXSL1000010 | 重组人凝血因子VIII融合蛋白 | Recombinant Coagulation Factor Ⅷ Fusion Protein | Other | Biological Products | Import Drug Application | 2010-03-19 | 杭州泰格医药科技有限公司 | Hangzhou Tigermed Consulting Co Ltd | Certificate Issued | 2011-12-29 | view |
JXSL1000009 | 重组人凝血因子VIII融合蛋白 | Recombinant Coagulation Factor Ⅷ Fusion Protein | Other | Biological Products | Import Drug Application | 2010-03-19 | 杭州泰格医药科技有限公司 | Hangzhou Tigermed Consulting Co Ltd | Certificate Issued | 2011-12-29 | view |
JXSL1000007 | 重组人凝血因子VIII融合蛋白 | Recombinant Coagulation Factor Ⅷ Fusion Protein | Other | Biological Products | Import Drug Application | 2010-03-23 | 杭州泰格医药科技有限公司 | Hangzhou Tigermed Consulting Co Ltd | Certificate Issued | 2011-12-29 | view |
JXSL1000008 | 重组人凝血因子VIII融合蛋白 | Recombinant Coagulation Factor Ⅷ Fusion Protein | Other | Biological Products | Import Drug Application | 2010-03-19 | 杭州泰格医药科技有限公司 | Hangzhou Tigermed Consulting Co Ltd | Certificate Issued | 2011-12-29 | view |
JXSS0600040 | 重组人凝血因子VIII | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products(7) | Import Drug Application | 2006-11-08 | 拜耳医药保健有限公司 | Bayer Healthcare Company Ltd | Certificate Issued | 2007-09-30 | view |
JXSS0600042 | 重组人凝血因子VIII | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products(7) | Import Drug Application | 2006-11-08 | 拜耳医药保健有限公司 | Bayer Healthcare Company Ltd | Certificate Issued | 2007-09-30 | view |
JXSS0600041 | 重组人凝血因子VIII | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products(7) | Import Drug Application | 2006-11-08 | 拜耳医药保健有限公司 | Bayer Healthcare Company Ltd | Certificate Issued | 2007-09-30 | view |
JYSB1600274 | 注射用重组人凝血因子Ⅷ | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2017-01-03 | | | Certificate Issued | 2017-04-10 | view |
JXSL1400062 | 注射用重组人凝血因子Ⅷ | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Import Drug Application | 2015-01-04 | 精鼎医药研究开发(上海)有限公司 | Parexel China Co Ltd | Certificate Issued | 2016-08-01 | view |
JYSB2000569 | 注射用重组人凝血因子Ⅷ | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2020-11-18 | | | Filed | 2020-12-01 | view |
JYSB1900086 | 注射用重组人凝血因子Ⅷ | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2019-04-24 | | | Certificate Issued | 2019-10-30 | view |
JYSB2200145 | 注射用重组人凝血因子Ⅷ | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2022-08-08 | | Bayer Healthcare LLC | | | view |
JYSB1700076 | 注射用重组人凝血因子Ⅷ | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2017-05-03 | | Bayer Healthcare LLC | Certificate Issued | 2018-06-15 | view |
CXSL1400063 | 注射用重组人凝血因子Ⅷ | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products(10) | New Drug Application | 2014-07-11 | 正大天晴药业集团股份有限公司 | Jiangsu Chia Tai-Tianqing Pharmaceutical Co Ltd | Certificate Issued | 2015-10-29 | view |
JYSB2400155 | 注射用重组人凝血因子Ⅷ | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2024-07-16 | | | | | view |
JYSB1800190 | 注射用重组人凝血因子Ⅷ | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2018-09-10 | | | Certificate Issued | 2019-02-02 | view |
JYSB2300035 | 注射用重组人凝血因子Ⅷ | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2023-02-23 | | Bayer Healthcare LLC | | | view |
JYSB1800045 | 注射用重组人凝血因子Ⅷ | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2018-03-23 | | Bayer Healthcare LLC | Certificate Issued | 2018-07-27 | view |
JYSZ2200049 | 注射用重组人凝血因子Ⅷ | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | License Renew | 2022-09-14 | | | | | view |
JYSB1500134 | 注射用重组人凝血因子Ⅷ | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2015-05-19 | | | Certificate Issued | 2017-03-27 | view |